There are 717 resources available
Invited Discussant abstracts 239MO and 240MO
Presenter: Pearly Khaw
Session: Mini oral session on Gynaecological tumours
Resources:
Slides
Webcast
Invited Discussant abstracts 241MO and 242MO
Presenter: David SP Tan
Session: Mini oral session on Gynaecological tumours
Resources:
Slides
Webcast
218MO - Comparison of a 22-gene genomic classifier (GC) with NCCN for risk stratification of Asian prostate cancers (PCa)
Presenter: Woo Wai Yee
Session: Mini oral session on Genitourinary tumours
Resources:
Abstract
Slides
Webcast
219MO - Real-world utilization pattern of bone-targeted agents for metastatic prostate cancer: Web-based questionnaire study by Hong Kong Society of Uro-Oncology (HKSUO)
Presenter: Darren Poon
Session: Mini oral session on Genitourinary tumours
Resources:
Abstract
Slides
Webcast
201MO - Real-world outcome of non-clear cell renal carcinoma patients: A single centre experience from Singapore
Presenter: Johan Chan
Session: Mini oral session on Genitourinary tumours
Resources:
Abstract
Slides
Webcast
202MO - Real-world outcomes of non-clear cell renal cell carcinoma: Retrospective study from tertiary cancer center in India
Presenter: amit choudhary
Session: Mini oral session on Genitourinary tumours
Resources:
Abstract
Slides
Webcast
80MO - Gut microbiome analysis for predicting neoadjuvant chemoradiotherapy response in locally advanced rectal cancer patients
Presenter: Yuxi Yi
Session: Mini oral session on Gastrointestinal tumours 2
Resources:
Abstract
Slides
Webcast
81MO - Clinical experience of a personalized and tumour-informed circulating tumour DNA assay for minimal residual disease detection in oligometastatic colorectal cancer patients
Presenter: Stacey Cohen
Session: Mini oral session on Gastrointestinal tumours 2
Resources:
Abstract
Slides
Webcast
82MO - Automatical risk stratifying for colorectal cancer by deep learning based pathological score
Presenter: Shenlun Chen
Session: Mini oral session on Gastrointestinal tumours 2
Resources:
Abstract
Slides
Webcast
83MO - AMG 510, a novel small molecule inhibitor of KRAS(G12C), for patients (pts) with advanced gastrointestinal (GI) cancers: Results from the CodeBreaK100 phase I trial
Presenter: Timothy Price
Session: Mini oral session on Gastrointestinal tumours 2
Resources:
Abstract
Slides
Webcast